rule

patient

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

This is one of those stocks that make it tempting to break my own personal trading rules to take a massive position.

My gut tells me this company has discipline and is following the rules of disclosures.

It can be shown that treatment bringing back independence is less costly than the nursing homes and medical staff.

$AVXL This may show why Anavex is definitely on the right path by using patients personal genetics to determine dosage.

Many claim him to be selfish and unconcerned with others, I see a different Missling, with humility and a deep concern for patients who are suffering.

Half the patients improved over baseline over 1 year.

Blarcamesine’s Phase III clinical trials show similar levels of significant improvement in communication and interaction, as patients had statistically significant improvement in the RSBQ primary endpoint of 72.2% compared to 38.5% on placebo. .

And better still for just those 85% carrying the normal SigmaR1 gene as well as for APOE2 and 3 patients.

new clinical trial results show great promise for treating early Alzheimer’s, giving renewed hope for effective treatments.

Anavex has over 760 patients that have taken it without any significant issues. .

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Novo Integrated Sciences Inc

crypto

$NVOS It would have been better to throw my money into crypto garbage than into this fire dumpster.

fire

This thing is not looking good, what was with that huge volume, yesterday, to end up being a complete dumpster fire.

investor

.slut
You are just a horrible investor 🤣🤣🤣

An increase in short sale volume suggests bearish (negative) sentiment among investors.

I hate the kind of investors stocks like this one attract.

$NVOS  just stop with the bs you are misleading people in a suggestive manner you gas lighting pos

I would like to return the bags for my money to the POS MGNT.

$NVOS just got interesting again with two more days of the uptick rule in place and the borrow fee still nudging upwards

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

$NVOS MAKE SENSE GO BUY BANK STOCK GO HIGHER THAN THIS SHIT.

$NVOS great buy here at these levels. ⏳🤑

service

price

Stock price will soar on this news alone and will go even higher with announcement of 180 day extension for Nasdaq compliance and positive earnings.

They are going through the stratosphere and the price just keeps going down.

$NVOS 
Added another good chunk at this price

Enjoy with your family and friends, and dont check the price every minut🤎

$NVOS thank you for this $.1211 price

Added 10k more….I’m buying every dip

Still very successful with holding the price down,

$NVOS Price movement looking very bullish at the moment.

KemPharm Inc

If the current staff is not able to get the job done, why are we still paying them?

but sho nuff in a mood about Corium not doing their job.

but still seeing plenty of reports of Azstarys availability issues at pharmacies (Coriums job).

KEEP YOUR FOCUS ON AZSTARYS AND DO YOUR DAMN JOB.

$KMPH Honest question, who keeps their high paying job and salary when you continually fail to deliver to share holders?

He’s done a bang-up job for them while shuttle cocking us!

$KMPH Richard Pascoe should be immediately fired from his phony do nothing job at Kempharm.

But yeah Corium and it&#39;s sales reps suck and are doing a bad job.

But I thought Travis was doing a good job?? !

hand

Warrants/Option have been handed out like candy on Halloween, decreasing shareholder value.

In mentioning the changes and additions, I noticed he didn&#39;t mention all these options/warrants they handed out reducing shareholder value.

We hand it over to Corium and they completely drop the ball and sales suck.

I went all in on kmph, and for the first time in a while, I don&#39;t feel great about the cards in my hand.

Create a new position or something to hand hold Perrys dumbass through this.

$KMPH Too bad Azstarys isn’t a schedule 19 drug, KemPharm could REALLY hand out their medications today 😁

$KMPH I think it’s hysterical that The Board stated that they bring quality &amp; experience meanwhile the truth shows another picture.

but too small (market cap &amp; volume wise) for me

Please send Travis &amp; Laduane to investor presentation school or get someone on the call who gets importance of presentation.

Travis sounded like he was underwater and hungover, LaDuane sounded sheepish, and the Q&amp;A was like a sprint.

So far board &amp; mgmt have proven weak.

$KMPH too many whiners &amp; bitches here

Maybe you should have put out a disclaimer that past  performance does not indicate future results?

The top line results were written in scientific gibberish.

If NDA submission was next quarter no one would be selling off before that catalyst. Disappointing.

$KMPH 
We need better results from Corium- NOW.

Two more quarters is a hard turkey to swallow when you’ve been waiting 14. #annualholidaymicklecuck

Unfortunately  the boost for KMPH is nullified by Travis&#39;  extension of 2 more quarters of dullness

This is a 2 quarter delay, that definitely sucks,

But  at this moment it is hard for me to accept the fact that we are delayed by 2 quarters.

product

Crappy calls are a by product of all this.

Told you this was dead money with that horrible management team and generic product.

Gotta make sure they not jacked up on their own product!

“Soccer moms” rule and once Mr. and Mrs. Joe Plumber learns that they can get all the benefits and virtually no side-effects of typical ADHD meds, I believe that Azstarys will practically sell itself.

&quot;This long term study reinforces the efficacy and safety of AZSTARYS as an important treatment option for healthcare professionals to consider when choosing the optimal ADHD therapy for their patients.&quot;

I recall an earlier posting last year of the same clinic who said patients were doing well and parents were liking the appetite benefits

$KMPH On the Facebook adhd forums, a mom said her sons doctor has had a few patients on azstarys and has had no complaints.

$KMPH 700 new patients last week I&#39;ll take that!

but again given the seasonality of ADHD in early school season combined with the Holidays, imo pretty OK. Actually gained more net new patients then Qelbree. .

However, what I like best is that it is working on actual patients.

Here&#39;s to a great 2023 with scripts continuing increasing by 500 plus patients per week, great IH results and submitting to the fda our arimiclomol application

So I am very positive this is a good treatment for me.

growth

Add in a little growth, and Zevra is in the black by Q4.

The manufacturing, marketing and distribution ARE in place and the script numbers ARE showing very solid growth.

$KMPH Quite impressive growth in scripts!

This is the script growth I&#39;ve been waiting for.

$KMPH This week we have MoM script growth, 24%, and YoY script growth, 748%. Nice!

New treatments and product launches: The development and launch of new and innovative treatments for ADHD, such as extended-release formulations and combination products, is also driving market growth.

No wonder we are seeing the exponential sales growth! !

news

The good news is that once our catalysts hit, this will all be water under the bridge ✌🏻

$KMPH https://twitter.com/zevratx/status/1629141771887300616?s=46&amp;t=mKynV6sCCjZ8XQfM2ymhxA

Great news!! !

Nevertheless good news, as it means the previous script number wasn&#39;t an outliner in the other direction either.

however like $KMPH all good news as a company with tons of potential.

And 4 year study is complete that&#39;s great news.

market

The market futures (so far) are looking positive on a Monday?

I am pleased with the SP! !🫡
(Especially on a Red Market day)

Good thing the market as a whole is thriving today, 🤣.

This will be a winner take all market and it feels good to have chosen the right horse.

but now we have new market conditions we can only dream about.

$kmph Jumped back i pre market for 1k starter 5.40&#39;s  scripts this week are a blowout!

$KMPH Well if the market is voting on hires Gallo is a 👍 😂

but I also believe the market is full of opportunities nowodays.

Top Stocks matching your search for "rules treated"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 1, 2023

Nov, 30, 2022

NVOS

Novo Integrated Sciences Inc

6.11%

$0.13 - $0.14

Mar, 9, 2023

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Jan, 1, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 1, 2023

Nov, 30, 2022

NVOS

Novo Integrated Sciences Inc

6.11%

$0.13 - $0.14

Mar, 9, 2023

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Jan, 1, 2023